intravenous thrombolysis for acute ischemic stroke due to cardiac myxoma

Background: myxoma may cause systemic embolization and frequently presents as ischemic stroke. case presentation: there have been debates about whether it is safe to use recombinant tissue plasminogen activator (rt-pa) in patients with cardiac myxoma who referred with ischemic stroke to the hospital's emergency. results: the patient was a young case of atrial myxoma with initial presentation of acute cerebral infarction symptoms who was treated with intravenous rt-pa with no complications. conclusion: the case provides an evidence of the efficacy and safety of intravenous rt-pa in cases of cardiac myxoma. however, we cannot always expect thrombolytic therapy to be effective, especially in tumor emboli.